Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas.

cFos.

Aberrant Cx43 Expression and Mislocalization in Metastatic Human Melanomas.

A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas.

CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas.

CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism.

Transposable hypomethylation is associated with metastatic capacity of primary melanomas.

Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: implications on optimized targeted therapy.

Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.

Surgery of primary melanomas.

Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation.

Clonal architectures and driver mutations in metastatic melanomas.

Expression of ProEx C in primary and metastatic urothelial carcinoma.

The expression of functional MSH receptors on cultured human melanocytes.

Hyperoside protects human primary melanocytes against H2O2-induced oxidative damage.

BRAFV600E protein expression in primary cutaneous malignant melanomas and paired metastases.

Immunobiology of primary murine melanomas.

Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas.

Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas.

Calcium transport and regulation in human primary and metastatic melanoma.

In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression.

Expression of cell surface sialic acid and galactose by normal adult human melanocytes in culture.

Metastatic disease from untreated uveal melanomas.

PDGFR axis in metastatic NSCLC.

Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells.

Suggest Documents

cFos.

Aberrant Cx43 Expression and Mislocalization in Metastatic Human Melanomas.

A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas.

CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas.

CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism.

Transposable hypomethylation is associated with metastatic capacity of primary melanomas.

Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: implications on optimized targeted therapy.

Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.

Surgery of primary melanomas.

Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation.

Clonal architectures and driver mutations in metastatic melanomas.

Expression of ProEx C in primary and metastatic urothelial carcinoma.

The expression of functional MSH receptors on cultured human melanocytes.

Hyperoside protects human primary melanocytes against H2O2-induced oxidative damage.

BRAFV600E protein expression in primary cutaneous malignant melanomas and paired metastases.

Immunobiology of primary murine melanomas.

Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas.

Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas.

Calcium transport and regulation in human primary and metastatic melanoma.

In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression.

Expression of cell surface sialic acid and galactose by normal adult human melanocytes in culture.

Metastatic disease from untreated uveal melanomas.

PDGFR axis in metastatic NSCLC.

Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells.

Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas.

Recommend Documents

Follow Us